Skip to content

Anxiety

Research spanning pharmacological, contemplative, and psychedelic-assisted approaches to pathological anxiety.

State of the evidence

Synthesized

Synthesized from 25 studies in the library · AI-generated, grounded in the abstracts below

Found by searching the library for Anxiety, generalized anxiety disorder, GAD, panic disorder, anxiety disorder, then ranked by relevance.

Mindfulness-based interventions and psychedelic-assisted therapies (psilocybin, LSD, ayahuasca) show consistent, moderate-to-large reductions in anxiety across diverse clinical populations, including cancer patients, psychiatric outpatients, and those with anxiety disorders. Effects are often sustained for months, but evidence is limited by small samples, lack of blinding, and heterogeneity in intervention protocols. Overall, the research supports these approaches as promising, but not definitive, treatments for anxiety.

Evidence by study

Direction is which way each study's own result points, not our rating of the study.

What the directions mean
Supports:
the study found the intervention worked, or its hypothesis held.
Opposes:
it found the opposite, no benefit or a harm.
No effect:
no significant difference either way.
Mixed:
effects in both directions within the same study.
Unclear:
the abstract does not report a direction.

MBCT significantly reduced relapse/recurrence in patients with three or more previous episodes, but not in those with only two episodes.

RCT Sample size: 145

Mindfulness meditation programs produced moderate reductions in anxiety at 8 weeks and small reductions at 3-6 months, but were not superior to active treatments.

meta-analysis Sample size: 3515

Mindfulness skills were differentially related to mental health constructs including neuroticism and psychological symptoms, but no direct effect on anxiety was reported.

psychometric study

High-dose psilocybin produced large and sustained decreases in anxiety and depression, with about 80% of participants showing clinically significant improvement at 6-month follow-up.

RCT Sample size: 51

A group mindfulness meditation program significantly reduced anxiety and panic symptoms, with reductions maintained at 3-month follow-up.

observational cohort Sample size: 22

Single-dose psilocybin plus psychotherapy produced rapid, substantial, and enduring reductions in anxiety and depression, with 60-80% of participants maintaining clinically significant improvements at 6.5 months.

double-blind, placebo-controlled, crossover trial Sample size: 29

Psilocybin occasioned mystical-type experiences and increased measures of mystical experience, but also produced acute anxiety and labile moods.

double-blind study Sample size: 36

Psilocybin was safe and associated with significant reductions in trait anxiety at 1 and 3 months after treatment.

double-blind, placebo-controlled study Sample size: 12

A mindfulness meditation-based stress reduction program significantly reduced total mood disturbance by 65% and stress symptoms by 31%, including anxiety subscales.

RCT Sample size: 90

Ayahuasca produced significantly greater reductions in depression severity than placebo at all time points over seven days, with large effect sizes.

RCT Sample size: 29

Oceanic boundlessness and dread of ego dissolution during psilocybin sessions predicted improvements in depressive symptoms at 5 weeks.

clinical trial Sample size: 20

Psilocybin was safely used in subjects with OCD and was associated with acute reductions in core OCD symptoms in several subjects.

controlled clinical trial

LSD-assisted psychotherapy significantly reduced trait and state anxiety at 2 months, with effects sustained for 12 months and no serious adverse events.

RCT Sample size: 12

Adolescents receiving MBSR showed reduced symptoms of anxiety, depression, and somatic distress, and increased self-esteem and sleep quality compared to treatment-as-usual controls.

RCT Sample size: 102

Mindfulness-based interventions are effective for improving anxiety and other biopsychosocial conditions, but evidence is inconclusive for several disorders and many studies are low quality.

review

Mindfulness-based interventions significantly reduced anxiety in breast cancer patients compared with control conditions, with a moderate effect size, but had no significant effect on sleep quality.

systematic review and meta-analysis Sample size: 3212

Argues that Detached Mindfulness may be feasible and acceptable in routine community mental health care, but current evidence does not establish efficacy or comparative effectiveness across anxiety disorders.

theoretical or philosophical paper

The Mindfulness–Acceptance–Commitment group showed significant reductions in cognitive and somatic anxiety and increased self-confidence, but the authors interpret these as preliminary due to club-based allocation.

quasi-experimental study Sample size: 30

Yoga nidra was feasible for autistic children, with medium effect sizes for reduced anxiety but no statistically significant changes; greater attendance was associated with self-reported anxiety reduction.

mixed methods feasibility and pilot efficacy study Sample size: 13

Sound-based meditation led to significantly lower anxiety, depression, salivary cortisol, and systolic blood pressure compared to music control, with no adverse events.

RCT Sample size: 100

Argues that anxiety is the mode in which apprehension of possible freedom first appears in consciousness, distinct from pathological anxiety, and that failing to realize this freedom turns anxiety into a trigger for despair or sin.

theoretical or philosophical paper

Brief mindfulness training modulated neurophysiological responses during working memory tasks, potentially reflecting improved attentional control, but no significant behavioral improvements were observed.

RCT

Mindfulness- and relaxation-based interventions decreased physical and psychosocial symptoms including anxiety, depression, and stress in women with PMS, improving quality of life.

systematic review Sample size: 1598

The abstract does not provide specific results, but it likely explores associations between trait mindfulness facets, anxiety, and cognitive performance in young adults.

observational cohort

Argues that meaning-centered contemplation, exemplified by Buddhist Nianfo practice, can reframe death anxiety and support existential orientation by reshaping self-referential patterns and loosening mortality-related rumination.

theoretical or philosophical paper

Points of agreement

  • Mindfulness-based interventions consistently reduce anxiety across diverse populations, including cancer patients, psychiatric outpatients, and adolescents.
  • Psychedelic-assisted therapies (psilocybin, LSD, ayahuasca) produce rapid and sustained reductions in anxiety and depression in clinical populations.
  • Effects of both mindfulness and psychedelic interventions are often sustained for months after treatment.
  • The quality of the acute psychedelic experience (e.g., mystical-type) may mediate therapeutic outcomes.

Conflicts

  • Mindfulness meditation programs were not superior to active treatments like drugs or exercise in one meta-analysis, while other studies show significant benefits over control conditions.
  • Some studies report no significant effect on sleep quality despite anxiety improvements, suggesting domain-specific effects.
  • A theoretical paper argues that anxiety is not inherently pathological, contrasting with clinical studies that treat anxiety as a symptom to be reduced.

Gaps

  • Most studies have small sample sizes and lack long-term follow-up beyond 6-12 months.
  • Blinding is often inadequate, especially in mindfulness and psychedelic trials, leading to potential expectancy effects.
  • Heterogeneity in intervention protocols, doses, and populations limits comparability across studies.
  • Few studies directly compare mindfulness-based interventions with psychedelic-assisted therapies for anxiety.
  • Evidence for specific populations (e.g., autistic children, athletes) is preliminary and requires replication.
Browse these studies in the library
How we analyze this

This synthesis reads the 15 most-cited and 10 most recent studies whose primary subject is Anxiety, up to 25 in all. The most-cited set anchors the established evidence, and the recent set surfaces work that is too new to have gathered citations yet.

A study qualifies only when Anxiety or a known alias appears in its title or keywords, so broad reviews that mention it only in passing are left out. Each study is read from its abstract, strongest evidence first, and the summary reports the direction of the results along with any conflicts and gaps.

Latest monthly recap: July 2026 →

5,049 articles · 2,128 from the last two years · 2,684,632 participants across 2,663 studies reporting sample size

Common study designs

review 702 systematic review 298 observational cohort 203 randomized controlled trial 711 theoretical or philosophical paper 297

The Association of a Mindfulness-Based Stress Reduction Nursing Model With Quality of Life in Patients With Chronic Tonsillitis Complicated by Anxiety Disorder: A Retrospective Study

Actas Españolas de Psiquiatría September 15, 2026 Xiaodan Zhang, Miao Wang, Qin Fu

Background: To examine the association between a mindfulness-based stress reduction (MBSR) nursing model and changes in quality of life in patients with chronic tonsillitis complicated by anxiety disorder. Methods: This retrospective study analyzed propensity score-matched data from 110 patients (55 per group) with chronic tonsillitis and comorbid anxiety disorder treated at Yingshang County...

Therapeutic Alliance and Perceived Closeness in MDMA-Assisted Therapy for Social Anxiety Disorder

September 11, 2026 Joseph M. Diehl, Christina Chwyl, Liliana Kennedy et al. preprint

The therapeutic relationship is considered central to psychedelic-assisted therapy, yet little empirical research has examined how it changes during 3,4-methylenedioxymethamphetamine-assisted therapy (MDMA-AT) or relates to acute MDMA experiences and clinical outcomes, particularly for social anxiety disorder (SAD). This preregistered secondary analysis examined therapeutic alliance and...

722. Predictors of therapeutic response to LSD in anxiety: short- and long-term outcomes

International Journal of Neuropsychopharmacology September 9, 2026 Friederike Holze, F Müller, Peter Gasser et al.

Abstract Background Anxiety disorders are a major health burden and current treatment options yield unsatisfactory results. Psychedelics, such as lysergic acid diethylamide (LSD) that act via agonism on serotonin 2A receptors, have recently been shown to be effective in the treatment of anxiety symptoms. Aims & Objectives Here, we determine the relationship between the acute experience and...

Perspective Chapter: Exploring Detached Mindfulness for Anxiety Disorders – Clinical and Implementation Insights from an Italian Mental Health Service

Mindfulness Across Disciplines [Working Title] September 2, 2026 Fabiola Raffone

Background/context: Anxiety disorders are common in community mental health services and are frequently maintained by worry, rumination, threat monitoring, reassurance seeking, avoidance, and maladaptive attempts to control internal experience. Aim/objective: This perspective chapter examines Detached Mindfulness as a metacognitive technique for anxiety disorders and discusses its clinical...

784. A Retrospective Report of Efficacy and Tolerability of Low Daily Dose Ketamine for Depression and Anxiety in a Large Population Sample

The International Journal of Neuropsychopharmacology September 1, 2026 A Nunes, J E Cunningham, B Leden et al.

Abstract Background Use of intravenous ketamine or intranasal esketamine for depression is frequently limited due to resource requirements and cost. Alternative treatment models have used oral, sublingual or intranasal racemic ketamine, but optimal doses and frequency of administration remain unclear. Dosing modelled from the standard 0.5-1.0mg/kg twice weekly IV ketamine result in transient...

Effects of a Sound-Based Meditative Intervention on Anxiety, Depression, Salivary Cortisol Levels, and Blood Pressure: A Randomized Controlled Trial.

Cureus September 2026 Hemachandran Ravikumar, Suresh Sathyanarayanan

Background Psychological stress contributes to mental health symptoms and cardiovascular risk through pathways involving anxiety, depression, cortisol secretion, autonomic dysregulation, and elevated blood pressure. Sound-based meditation is a nonpharmacological approach that may support stress management, but randomized controlled trial evidence remains limited. Objective The objective was to...

Effects of an 8-week Mindfulness–Acceptance–Commitment intervention on competitive anxiety, mindfulness, and 200-m sprint performance in junior female sprinters: a quasi-experimental study

Sport Sciences for Health September 1, 2026 Chiraz Goumni, Amayra Tannoubi, Aymen Hawani et al.

Abstract Background Competitive anxiety is a critical factor influencing performance in explosive, self-paced sports such as sprinting. Although mindfulness and acceptance-based approaches are increasingly used in sport psychology, evidence for their effects in young female track athletes remains limited. Purpose This quasi-experimental study examined the effects of an 8 week...

Co-designed yoga nidra targeting anxiety in autistic children: A mixed methods feasibility study.

Research in developmental disabilities September 2026 Tundi Loftus, Shu H Yau, Sophia Soares et al.

Autistic children experience disproportionately high rates of anxiety, yet common interventions such as cognitive behavioural therapy and traditional mindfulness practices may be less effective due to their cognitive and abstract demands. Yoga nidra, a form of guided meditation using concrete visualisations and breath awareness, may offer a more accessible alternative. This mixed methods study...

Kierkegaard’s Concept of Anxiety

August 31, 2026 George Pattison

With reference to Kierkegaard's religious writings and other pseudonymous works, Kierkegaard's concept of anxiety is explored with a primary focus on the book The Concept of Anxiety. Anxiety itself is shown to be the eminent term for a moment in the human being's psychological development that Kierkegaard also discusses in other terms. In particular, it is the mode in which human being's...

Clinical trials

All Anxiety trials →